COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,441 Articles (22,835 medRxiv, 8,606 bioRxiv)

Most recent first Previous |  Page 2326: Articles 23251-23260  | Next

Perturbations in the mononuclear phagocyte landscape associated with COVID-19 disease severity
Kvedaraite, E., Hertwig, L., Sinha, I., Ponzetta, A., Hed Myrberg, I., Lourda, M., Dzidic, M., Akber, M., Klingstrom, J., Folkesson, E., Muvva, R., Chen, P., Brighenti, S., Norrby-Teglund, A., Eriksson, L. I., Rooyackers, O., Aleman, S., Stralin, K., Ljunggren, H.-G., Ginhoux, F., Bjorkstrom, N., Henter, J.-I., Svensson, M.
10.1101/2020.08.25.20181404 — Posted: 2020-08-31
Interplay of antibody and cytokine production reveals CXCL-13 as a potential novel biomarker of lethal SARS-CoV-2 infection
Horspool, A. M., Kieffer, T., Russ, B. P., DeJong, M. A., Wolf, M. A., Karakiozis, J. M., Hickey, B. J., Fagone, P., Tacker, D. H., Bevere, J. R., Martinez, I., Barbier, M., Perrotta, P. L., Damron, F. H.
10.1101/2020.08.24.20180877 — Posted: 2020-08-31
Viral shedding and immunological features of children COVID-19 patients
Yang, Y., Zheng, H., Peng, L., Wei, J., Wang, Y., Li, X., Peng, B., Fang, S., Zhang, M., Liu, H., Li, Y., Feng, K., Xing, L., Wang, J., Cao, M., Wang, F., Liu, Y., Liu, L., Yuan, J.
10.1101/2020.08.25.20181446 — Posted: 2020-08-31
From Face-to-Face to Online Modality: Implications for Undergraduate Learning While the World is Temporarily Closed in the Age of COVID-19
Hacisalihoglu, G.
10.1101/2020.08.30.274506 — Posted: 2020-08-31 Discussion: Onsite
Methylene Blue Inhibits In Vitro the SARS-CoV-2 Spike - ACE2 Protein-Protein Interaction - A Mechanism That Can Contribute to Its Antiviral Activity Against COVID-19
Bojadzic, D., Alcazar, O., Buchwald, P.
10.1101/2020.08.29.273441 — Posted: 2020-08-31
A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses
Tan, T. K., Rijal, P., Rahikainen, R., Keeble, A., Schimanski, L., Hussain, S., Harvey, R., Hayes, J., Edwards, J., McLean, R., Martini, V., Pedrera, M., Thakur, N., Conceicao, C., Dietrich, I., Shelton, H., Ludi, A. B., Wilsden, G., Browning, C., Zagrajek, A., Bialy, D., Bhat, S., Stevenson-Leggett, P., Hollinghurst, P., Tully, M., Moffat, K., Chiu, C., Waters, R., Gray, A., Azhar, M., Mioulet, V., Newman, J., Asfor, A. S., Burman, A., Crossley, S., Hammond, J., Tchilian, E., Charleston, B., Bailey, D., Tuthill, T. J., Graham, S., Malinauskas, T., Huo, J., Tree, J., Buttigieg, K., Owens, R., Carroll, M., Daniels, R., McCauley, J., Huang, K.-Y. A., Howarth, M., Townsend, A.
10.1101/2020.08.31.275701 — Posted: 2020-08-31
ACE2 and SARS-CoV-2 Expression in the Normal and COVID-19 Pancreas
Kusmartseva, I., Wu, W., Syed, F., van der Heide, V., Jorgensen, M., Joseph, P., Tang, X., Candelario-Jalil, E., Yang, C., Nick, H., Harbert, J., Posgai, A. L., Lloyd, R., Cechin, S., Pugliese, A., Campbell-Thompson, M., Vander Heide, R. S., Evans-Molina, C., Homann, D., Atkinson, M. A.
10.1101/2020.08.31.270736 — Posted: 2020-08-31
Ebselen derivatives are very potent dual inhibitors of SARS-CoV-2 proteases - PLpro and Mpro in in vitro studies
Zmudzinski, M., Rut, W., Olech, K., Granda, J., Giurg, M., Burda-Grabowska, M., Zhang, L., Sun, X., Lv, Z., Nayak, D., Kesik-Brodacka, M., Olsen, S., Hilgenfeld, R., Drag, M.
10.1101/2020.08.30.273979 — Posted: 2020-08-31
SARS-CoV-2 Cell Entry Factors ACE2 and TMPRSS2 are Expressed in the Pancreas but Not in Islet Endocrine Cells
Coate, K. C., Cha, J., Shrestha, S., Wang, W., Fasolino, M., Morgan, A., Dai, C., Saunders, D. C., Aramandla, R., Jenkins, R., Kapp, M. E., Stein, R., Kaestner, K. H., Vahedi, G., Brissova, M., Powers, A. C.
10.1101/2020.08.31.275719 — Posted: 2020-08-31
Optimising social mixing strategies to mitigate the impact of COVID-19 in six European countries: a mathematical modelling study
Ragonnet, R., Briffoteaux, G., Williams, B. M., Savulescu, J., Segal, M., Abayawardana, M., Eggo, R. M., Tuyttens, D., Melab, N., Marais, B. J., McBryde, E. S., Trauer, J. M.
10.1101/2020.08.25.20182162 — Posted: 2020-08-31

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).